These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23330092)

  • 21. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
    Zhou XJ; Li Q; Chen WT
    Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor.
    Okamura T; Singh S; Buolamwini J; Haystead T; Friedman H; Bigner D; Ali-Osman F
    J Biol Chem; 2009 Jun; 284(25):16979-16989. PubMed ID: 19254954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
    Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
    Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line.
    Kumar U; Sharma U; Rathi G
    Tumour Biol; 2017 Feb; 39(2):1010428317692258. PubMed ID: 28222671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S‑transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.
    Zou M; Hu X; Xu B; Tong T; Jing Y; Xi L; Zhou W; Lu J; Wang X; Yang X; Liao F
    Oncol Rep; 2019 Feb; 41(2):989-998. PubMed ID: 30431119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.
    Peklak-Scott C; Smitherman PK; Townsend AJ; Morrow CS
    Mol Cancer Ther; 2008 Oct; 7(10):3247-55. PubMed ID: 18852128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells.
    Lin C; Xie L; Lu Y; Hu Z; Chang J
    Int J Mol Med; 2018 Apr; 41(4):2050-2058. PubMed ID: 29328427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro].
    Cai LQ; Li M; Lu S; Wang HB; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):478-81. PubMed ID: 15347473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ
    Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
    Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
    Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene.
    Lo HW; Stephenson L; Cao X; Milas M; Pollock R; Ali-Osman F
    Mol Cancer Res; 2008 May; 6(5):843-50. PubMed ID: 18505928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells.
    Morceau F; Duvoix A; Delhalle S; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2004 Apr; 67(7):1227-38. PubMed ID: 15013838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
    Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
    Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
    Wang X; Zhu J
    Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.
    Okuyama T; Maehara Y; Endo K; Baba H; Adachi Y; Kuwano M; Sugimachi K
    Cancer; 1994 Aug; 74(4):1230-6. PubMed ID: 8055443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
    Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
    Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.